A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612AM4)(COMPLETED) (ESAQUALITY)
This study has been completed.
Study NCT00687401
Information provided by Schering-Plough
First Received on May 27, 2008.
Last Updated on January 27, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
